Join the Arava group to help and get support from people like you.
Arava News
Benefits of Long-Term Routine Lab Drug Toxicity Monitoring Unclear in RA
TUESDAY, Aug. 26, 2025 – For patients with rheumatoid arthritis (RA) using disease-modifying antirheumatic drugs (DMARDs), long-term routine laboratory toxicity monitoring (lt-RLTM) indicates that...
FDA Medwatch Alert: Arava (leflunomide)
Aventis Pharmaceuticals and FDA updated the prescribing information for Arava (leflunomide), indicated for the treatment of active rheumatoid arthritis. In postmarketing experience worldwide, rare,...